These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 20005149)

  • 21. Hyperocclusion up-regulates CCL3 expression in CCL2- and CCR2-deficient mice.
    Tsutsumi T; Kajiya H; Goto KT; Takahashi Y; Okabe K
    J Dent Res; 2013 Jan; 92(1):65-70. PubMed ID: 23143790
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Crucial role of the CCL2/CCR2 axis in neointimal hyperplasia after arterial injury in hyperlipidemic mice involves early monocyte recruitment and CCL2 presentation on platelets.
    Schober A; Zernecke A; Liehn EA; von Hundelshausen P; Knarren S; Kuziel WA; Weber C
    Circ Res; 2004 Nov; 95(11):1125-33. PubMed ID: 15528472
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting CCL2 with systemic delivery of neutralizing antibodies induces prostate cancer tumor regression in vivo.
    Loberg RD; Ying C; Craig M; Day LL; Sargent E; Neeley C; Wojno K; Snyder LA; Yan L; Pienta KJ
    Cancer Res; 2007 Oct; 67(19):9417-24. PubMed ID: 17909051
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CCL2 But Not CCR2 Is Required for Spontaneous Articular Cartilage Regeneration Post-Injury.
    Jablonski CL; Leonard C; Salo P; Krawetz RJ
    J Orthop Res; 2019 Dec; 37(12):2561-2574. PubMed ID: 31424112
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is the C-C Motif Ligand 2-C-C Chemokine Receptor 2 Axis a Promising Target for Cancer Therapy and Diagnosis?
    Iwamoto H; Izumi K; Mizokami A
    Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33297571
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CCR2 signaling in breast carcinoma cells promotes tumor growth and invasion by promoting CCL2 and suppressing CD154 effects on the angiogenic and immune microenvironments.
    Brummer G; Fang W; Smart C; Zinda B; Alissa N; Berkland C; Miller D; Cheng N
    Oncogene; 2020 Mar; 39(11):2275-2289. PubMed ID: 31827233
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of the CCL2-CCR2 signalling axis in cancer: Mechanisms and therapeutic targeting.
    Xu M; Wang Y; Xia R; Wei Y; Wei X
    Cell Prolif; 2021 Oct; 54(10):e13115. PubMed ID: 34464477
    [TBL] [Abstract][Full Text] [Related]  

  • 28. RANKL promotes the growth of decidual stromal cells in an autocrine manner via CCL2/CCR2 interaction in human early pregnancy.
    Meng YH; Li H; Chen X; Liu LB; Shao J; Chang KK; Du MR; Jin LP; Li MQ; Li DJ
    Placenta; 2013 Aug; 34(8):663-71. PubMed ID: 23697850
    [TBL] [Abstract][Full Text] [Related]  

  • 29. C-C motif chemokine ligand 2 induces proliferation and prevents lipopolysaccharide-induced inflammatory responses in bovine mammary epithelial cells.
    Yang C; Lim W; Bae H; Bazer FW; Song G
    J Dairy Sci; 2018 May; 101(5):4527-4541. PubMed ID: 29454702
    [TBL] [Abstract][Full Text] [Related]  

  • 30. FAP Promotes Immunosuppression by Cancer-Associated Fibroblasts in the Tumor Microenvironment via STAT3-CCL2 Signaling.
    Yang X; Lin Y; Shi Y; Li B; Liu W; Yin W; Dang Y; Chu Y; Fan J; He R
    Cancer Res; 2016 Jul; 76(14):4124-35. PubMed ID: 27216177
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Estrogen promotes progression of hormone-dependent breast cancer through CCL2-CCR2 axis by upregulation of Twist via PI3K/AKT/NF-κB signaling.
    Han R; Gu S; Zhang Y; Luo A; Jing X; Zhao L; Zhao X; Zhang L
    Sci Rep; 2018 Jun; 8(1):9575. PubMed ID: 29934505
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chemokine (C-C motif) ligand 2 engages CCR2+ stromal cells of monocytic origin to promote breast cancer metastasis to lung and bone.
    Lu X; Kang Y
    J Biol Chem; 2009 Oct; 284(42):29087-96. PubMed ID: 19720836
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumor-associated macrophages secrete CC-chemokine ligand 2 and induce tamoxifen resistance by activating PI3K/Akt/mTOR in breast cancer.
    Li D; Ji H; Niu X; Yin L; Wang Y; Gu Y; Wang J; Zhou X; Zhang H; Zhang Q
    Cancer Sci; 2020 Jan; 111(1):47-58. PubMed ID: 31710162
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TR4 nuclear receptor promotes prostate cancer metastasis via upregulation of CCL2/CCR2 signaling.
    Ding X; Yang DR; Lee SO; Chen YL; Xia L; Lin SJ; Yu S; Niu YJ; Li G; Chang C
    Int J Cancer; 2015 Feb; 136(4):955-64. PubMed ID: 24975468
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A destructive cascade mediated by CCL2 facilitates prostate cancer growth in bone.
    Li X; Loberg R; Liao J; Ying C; Snyder LA; Pienta KJ; McCauley LK
    Cancer Res; 2009 Feb; 69(4):1685-92. PubMed ID: 19176388
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of chemokines in CNS health and pathology: a focus on the CCL2/CCR2 and CXCL8/CXCR2 networks.
    Semple BD; Kossmann T; Morganti-Kossmann MC
    J Cereb Blood Flow Metab; 2010 Mar; 30(3):459-73. PubMed ID: 19904283
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Importance of chemokine (CC-motif) ligand 2 in breast cancer.
    Steiner JL; Murphy EA
    Int J Biol Markers; 2012 Oct; 27(3):e179-85. PubMed ID: 22865298
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tubular GM-CSF Promotes Late MCP-1/CCR2-Mediated Fibrosis and Inflammation after Ischemia/Reperfusion Injury.
    Xu L; Sharkey D; Cantley LG
    J Am Soc Nephrol; 2019 Oct; 30(10):1825-1840. PubMed ID: 31315923
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CCL2/CCR2 signaling pathway in glioblastoma multiforme.
    Vakilian A; Khorramdelazad H; Heidari P; Sheikh Rezaei Z; Hassanshahi G
    Neurochem Int; 2017 Feb; 103():1-7. PubMed ID: 28025034
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CCL3/CCR1 mediates CD14
    Zhao X; Gu M; Xu X; Wen X; Yang G; Li L; Sheng P; Meng F
    Osteoarthritis Cartilage; 2020 May; 28(5):613-625. PubMed ID: 32006659
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.